Thyroid carcinoma.

By S. Sherman, P. Angelos, D. Ball, D. Byrd, O. Clark, G. Daniels, R. Dilawari, H. Ehya, W. Farrar, R. Gagel and 13 more. The Journal of the National Comprehensive Cancer Network, 2007

1,017 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/9803fea1470e93851793cea6268098cd294d00a8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Mingzhao Xing
2. V. Gupta-Abramson
3. Michael Mingzhao Xing
4. G. Francis
5. M. Brose
6. Andrea B. Troxel
7. M. Luster
8. K. Flaherty

Citations in the corpus

• BRAF mutation in thyroid cancer. (2005, background): “However, it has long been known that childhood radiation exposure is associated with a higher incidence of thyroid cancer (Duffy & Fitzgerald 1950, Wood et al. 1969, Shore et al. 1985).”
• American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer (2012, unknown): “The National Comprehensive Cancer Network devotes 37 pages to treating and following DTC patients but only three pages for ATC (9).”
• Molecular pathogenesis and mechanisms of thyroid cancer (2013, background): “Activated PI3K catalyses the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)trisphosphate (PIP3).”
• Phase II trial of sorafenib in advanced thyroid cancer. (2008, background): “papillary and follicular subtypes and comprises 90% of all cases of thyroid cancer.(2) Once thyroid cancer”
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer (2015, background): “In clinical practice, the initial evaluation and treatment of FTC in children is generally the same as for PTC (200,395).”